{'52WeekChange': None,
 'SandP52WeekChange': None,
 'address1': '460 Bourke Street',
 'address2': 'Level 3',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 1.45,
 'askSize': 4000,
 'averageDailyVolume10Day': 180762,
 'averageVolume': 1957546,
 'averageVolume10days': 180762,
 'beta': 0.419767,
 'beta3Year': None,
 'bid': 1.44,
 'bidSize': 1100,
 'bookValue': None,
 'category': None,
 'circulatingSupply': None,
 'city': 'Melbourne',
 'companyOfficers': [],
 'country': 'Australia',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 1.45,
 'dayLow': 1.42,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': None,
 'enterpriseToRevenue': None,
 'enterpriseValue': 21088168,
 'exDividendDate': None,
 'exchange': 'NCM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 1.062,
 'fiftyTwoWeekHigh': 2.35,
 'fiftyTwoWeekLow': 0.28,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 9964378,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fullTimeEmployees': 14,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0,
 'heldPercentInstitutions': 0.01959,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1561852800,
 'lastMarket': None,
 'lastSplitDate': 1458777600,
 'lastSplitFactor': '1:6',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/alteritytherapeutics.com',
 'longBusinessSummary': 'Alterity Therapeutics Limited researches and develops '
                        "therapeutic drugs for the treatment of Alzheimer's "
                        "disease, Huntington disease, Parkinson's disease, and "
                        'other neurological disorders in Australia. The '
                        "company's lead drug candidates include PBT434 that is "
                        'in Phase I clinical trial for the treatment of '
                        "Parkinson's disease and other movement disorders. It "
                        "is also developing PBT2 for patients with Alzheimer's "
                        'disease. The company was formerly known as Prana '
                        'Biotechnology Limited and changed its name to '
                        'Alterity Therapeutics Limited in April 2019. The '
                        'company was founded in 1997 and is based in '
                        'Melbourne, Australia.',
 'longName': 'Alterity Therapeutics Limited',
 'market': 'us_market',
 'marketCap': 27883066,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_2383747',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1577750400,
 'navPrice': None,
 'netIncomeToCommon': None,
 'nextFiscalYearEnd': 1625011200,
 'open': 1.43,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '61 3 9349 4906',
 'previousClose': 1.44,
 'priceHint': 4,
 'priceToBook': None,
 'priceToSalesTrailing12Months': None,
 'profitMargins': -2.88547,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 1.45,
 'regularMarketDayLow': 1.42,
 'regularMarketOpen': 1.43,
 'regularMarketPreviousClose': 1.44,
 'regularMarketPrice': 1.43,
 'regularMarketVolume': 50146,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 18083400,
 'sharesPercentSharesOut': 0.0005,
 'sharesShort': 6771,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 11504,
 'shortName': 'Alterity Therapeutics Limited',
 'shortPercentOfFloat': None,
 'shortRatio': 0.01,
 'startDate': None,
 'state': 'VIC',
 'strikePrice': None,
 'symbol': 'ATHE',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': None,
 'twoHundredDayAverage': 0.7631655,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '7d2b4277-cadd-3872-afb9-8272c07044dd',
 'volume': 50146,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.alteritytherapeutics.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '3000'}